Our approach shows that the integration of assays for NF1/SPRED1 pre-mRNA splicing and protein function allows reclassification of a significant proportion of NF1 and SPRED1 VUS, drastically improving molecular diagnostics for individuals and families with NF1 and LS. The gene discussed is SPRED1; the disease is Leigh syndrome.